On the path towards universal coverage of hepatitis C treatment among people receiving opioid agonist therapy (OAT) in Norway: a prospective cohort study from 2013 to 2017

by Peter Vickerman, Ingvild Odsbu, Kjell Arne Johansson, Jørn Henrik Vold, Fatemeh Chalabianloo, Christer Frode Aas, Jan Magnus Økland, Rafael Alexander Modahl Leiva, Lars T Fadnes
Published 2020-08-01

Correction: Incidence and prevalence of inflammatory bowel disease in UK primary care: a population-based cohort study

by Peter Vickerman, Ingvild Odsbu, Kjell Arne Johansson, Jørn Henrik Vold, Fatemeh Chalabianloo, Christer Frode Aas, Jan Magnus Økland, Rafael Alexander Modahl Leiva, Lars T Fadnes
Published 2020-08-01

Substance use and symptoms of mental health disorders: a prospective cohort of patients with severe substance use disorders in Norway

by Christer Frode Aas, Jørn Henrik Vold, Rolf Gjestad, Svetlana Skurtveit, Aaron Guanliang Lim, Kristian Varden Gjerde, Else-Marie Løberg, Kjell Arne Johansson, Lars Thore Fadnes, for the INTRO-HCV Study Group
Published 2021-02-01

Health-related quality of life of long-term patients receiving opioid agonist therapy: a nested prospective cohort study in Norway

by Christer Frode Aas, Jørn Henrik Vold, Svetlana Skurtveit, Aaron G. Lim, Sabine Ruths, Kamrul Islam, Jan Erik Askildsen, Else-Marie Løberg, Lars Thore Fadnes, Kjell Arne Johansson, for the INTRO-HCV Study Group
Published 2020-09-01

Integrated treatment of hepatitis C virus infection among people who inject drugs: study protocol for a randomised controlled trial (INTRO-HCV)

by Lars T. Fadnes, Christer Frode Aas, Jørn Henrik Vold, Christian Ohldieck, Rafael Alexander Leiva, Fatemeh Chalabianloo, Svetlana Skurtveit, Ole Jørgen Lygren, Olav Dalgård, Peter Vickerman, Håvard Midgard, Else-Marie Løberg, Kjell Arne Johansson, for the INTRO-HCV Study Group
Published 2019-11-01

Integrated treatment of hepatitis C virus infection among people who inject drugs: A multicenter randomized controlled trial (INTRO-HCV).

by Lars T Fadnes, Christer Frode Aas, Jørn Henrik Vold, Rafael Alexander Leiva, Christian Ohldieck, Fatemeh Chalabianloo, Svetlana Skurtveit, Ole Jørgen Lygren, Olav Dalgård, Peter Vickerman, Håvard Midgard, Else-Marie Løberg, Kjell Arne Johansson, INTRO-HCV Study Group
Published 2021-06-01